Search - tctmd.com

Displaying 21 - 40 of 281

Sort: Relevancy | Date

Presentation THT 2024

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Presenter: Ioana Preston

March 06, 2024

Presentation THT 2024

Counter Pulsation of the PA: Aria CV

Presenter: Jane A. Leopold

March 06, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

PADN for PH in Left Heart Disease

Presenter: Greg Lewis

March 06, 2024

Presentation THT 2024

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Presenter: Thomas Hanff

March 06, 2024

Presentation THT 2024

Pulmonary Artery Denervation

Presenter: Alex M. K. Rothman

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

PH-HFpEF: Levosimendan

Presenter: Sanjiv J. Shah

March 06, 2024

Presentation THT 2024

Disaggregating Left Heart Disease-Pulmonary Hypertension

Presenter: Bradley A. Maron

March 06, 2024

Presentation THT 2024

Pulsatile ECMO

Presenter: Nader Moazami

March 06, 2024

Presentation THT 2024

RV-PA Coupling and PV Loops: The Art of Hemodynamics

Presenter: Ryan J. Tedford

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

Reclassification of PH Based with New Endo-Phenotypes

Presenter: Evelyn Miriam Horn

March 06, 2024

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

Presentation THT 2024

Post PE Syndrome

Presenter: Paul Forfia

March 06, 2024

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Presenter: Candice Lee

March 06, 2024

Presentation THT 2024

Multicenter Development and Validation of a Supervised Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

Presenter: Stavros G. Drakos

March 06, 2024

Advertisement

One Ring to Rule Them All: The Promise of Sotatercept in PH (PAH and Left Heart Disease)

Counter Pulsation of the PA: Aria CV

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

PADN for PH in Left Heart Disease

Emerging Therapies for Residual Pulmonary Hypertension After Pulmonary Endarterectomy

A Novel Study Design, Termed Molecular Triangulation, That Leverages Biologic Similarities Across Seemingly Different Shock Phenotypes In Order to Identify Novel Druggable Targets and Pathophysiologic Mechanisms.

Pulmonary Artery Denervation

DPP3-Based Biotherapy in Cardiogenic Shock

PH-HFpEF: Levosimendan

Disaggregating Left Heart Disease-Pulmonary Hypertension

Pulsatile ECMO

RV-PA Coupling and PV Loops: The Art of Hemodynamics

Ivabridine in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

Reclassification of PH Based with New Endo-Phenotypes

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Post PE Syndrome

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Contemporary Management of High-Risk PE: Focus on Temporary MCS Therapies and Surgical Thrombectomy

Multicenter Development and Validation of a Supervised Machine Learning Risk Model to Predict Right Ventricular Failure Following Mechanical Circulatory Support: The STOP-RVF Score

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content